Refine
Year of publication
Document Type
- Article (218)
- Preprint (92)
- Conference Proceeding (4)
- Book (2)
- Review (2)
Language
- English (303)
- German (14)
- Multiple languages (1)
Has Fulltext
- yes (318)
Is part of the Bibliography
- no (318)
Keywords
- BESIII (9)
- Branching fraction (7)
- e +-e − Experiments (7)
- Lepton colliders (4)
- Particle and Resonance Production (4)
- Charm Physics (3)
- Charmed mesons (3)
- Electroweak interaction (3)
- Hadronic decays (3)
- e+-e− Experiments (3)
- Biomarkers (2)
- Branching fractions (2)
- CV9202 (2)
- Charm physics (2)
- Consensus (2)
- Diagnostik (2)
- Electroweak Interaction (2)
- Exotics (2)
- Früherkennung (2)
- Leptonic, semileptonic & radiative decays (2)
- MRI (2)
- Mammakarzinom (2)
- Nachsorge (2)
- Non-small cell lung cancer (2)
- Oncology (2)
- Particle decays (2)
- Polarization (2)
- Quarkonium (2)
- Rehabilitation (2)
- Richtlinie (2)
- SARS-CoV-2 (2)
- Spectroscopy (2)
- breast cancer (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- screening (2)
- ACL (1)
- ATM (1)
- Actin (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Acute inflammation (1)
- Acute myeloid leukemia (1)
- Alzheimer's disease (1)
- Animal models (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Antirheumatic agents (1)
- Archaeogeophysics (1)
- Ascites (1)
- Auditory system (1)
- Austria (1)
- Automata theory (1)
- B cell receptor (1)
- BESIII detector (1)
- BI1361849 (1)
- BPDCN (1)
- Berci needle (1)
- Bevacizumab (1)
- Bhabha (1)
- Bone conduction devices (1)
- Born cross section measurement (1)
- BrainNet Europe consortium (1)
- Business strategy in drug development (1)
- Bypass liner (1)
- C1-INH (C1 inhibitor, C1-esterase inhibitor) (1)
- CAKUT (1)
- CDKN2A (1)
- COVID-19 (1)
- CP violation (1)
- CRISPR/Cas (1)
- Cancer (1)
- Capecitabine (1)
- Cardiomyopathy (1)
- Carex firma community (1)
- Carex sempervirens community (1)
- Caricion davallianae (1)
- Charmonia (1)
- Charmonium (1)
- Charmonium (-like) (1)
- Cherenkov counter: lead-glass (1)
- Child (1)
- Chondral Lesion (1)
- Cirrhosis (1)
- Claudin 5 (1)
- Clinical trial (1)
- Cognitive impairment (1)
- Cohort studies (1)
- Comparative effectiveness research (1)
- Complex I (1)
- Consensus statement (1)
- Covid-19 (1)
- Cross section (1)
- D meson (1)
- Dark photon (1)
- Dark sector (1)
- Dermatomyositis (1)
- Diabetes (1)
- Diagnosis (1)
- Diagnostic differentiation (1)
- Diagnostic markers (1)
- Dilated cardiomyopathy (1)
- Direct oral anticoagulation (1)
- Drug screens (1)
- Drug therapy (1)
- Dumon stents (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Electron-pion identification (1)
- Endoscopy (1)
- Esophageal adenocarcinoma (1)
- Exercise (1)
- Experimental nuclear physics (1)
- Experimental particle physics (1)
- FAPI PET (1)
- FOS: Physical sciences (1)
- Fagus sylvatica (1)
- Festuco-Brometea (1)
- Fibre/foam sandwich radiator (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Flavour Physics (1)
- Form factors (1)
- Full waveform (1)
- Function (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Genome editing (1)
- Glioblastoma survival (1)
- HADES (1)
- HIV (1)
- HIV-1 (1)
- Haploidentical stem cell transplantation (1)
- Harz Mountains foothills (1)
- Health policy (1)
- Heart (1)
- Heart transplantation (1)
- Heavy ion storage ring (1)
- Hematology (1)
- Hepatitis C virus (1)
- Hereditary angioedema (1)
- High Energy Physics - Experiment (hep-ex) (1)
- Hsp70 (1)
- Hyperons (1)
- Hypofractionated radiotherapy (1)
- IHC (1)
- Immunomonitoring (1)
- Infinite games with perfect information (1)
- Initial state radiation (1)
- Interpretation (1)
- Intragastric balloon (1)
- Inversion (1)
- Invisible decays (1)
- Ionisation energy loss (1)
- KIR (1)
- KRAS (1)
- Lactic acidosis (1)
- Leukemias (1)
- Liver diseases (1)
- Liver transplantation (1)
- Low-molecular-weight heparin (1)
- MEDIC (1)
- MLL (1)
- Mena/VASP (1)
- Minimal residual disease (1)
- Mitochondrial disorder (1)
- Mixed hearing loss (1)
- Molecular diagnostic testing (1)
- Molinio-Arrhenatheretea (1)
- Multi-stakeholder approach (1)
- Multi-wire proportional drift chamber (1)
- NK cells (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NRAS (1)
- Neonatal (1)
- Neural network (1)
- Neutrinos (1)
- Noninferiority (1)
- Obesity (1)
- Orbital electron capture (1)
- Ovarian cancer (1)
- Oxaliplatin (1)
- PDE‐5‐inhibitor (1)
- Parkinson disease (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Patellofemoral Joint (1)
- Pediatric (1)
- Physiotherapy (1)
- Preoperative radiochemotherapy (1)
- Prognosis (1)
- Proton (1)
- Pulmonary embolism (1)
- QCD (1)
- Quantum chromodynamics (1)
- RHIC (1)
- RNActive (1)
- Radiative decay (1)
- Rare decays (1)
- Rectal cancer (1)
- Registries (1)
- Renal lesions (1)
- Renal replacement therapy (1)
- Respiration (1)
- SCCHN (1)
- SLC20A1 (1)
- STAR (1)
- STIR (1)
- Semi-leptonic decays (1)
- Single particle decay spectroscopy (1)
- Single-leg hop for distance (1)
- Spectrin (1)
- Spin alignment (1)
- Surgery (1)
- TILs (1)
- TLR2/6 (1)
- TR (1)
- Technical data (1)
- Techniques Electromagnetic calorimeters (1)
- Therapeutic anticoagulation (1)
- Tomography (1)
- Tracking (1)
- Transition radiation detector (1)
- Treatment (1)
- Trigger (1)
- Two body weak decay (1)
- VE-cadherin (1)
- VEGF (1)
- VISTA (1)
- Validity (1)
- Vascular permeability (1)
- Violion caninae (1)
- Vitamin (1)
- Weight loss (1)
- Xenon-based gas mixture (1)
- Y states (1)
- acute myeloid leukemia (1)
- adult and elderly patients (1)
- aegean (1)
- airway (1)
- algorithms (1)
- alpine vegetation (1)
- angiogenesis (1)
- annual bleeding rate (1)
- arteriogenesis (1)
- artifacts (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- auditory system (1)
- beech forests (1)
- bladder exstrophy-epispadias complex (1)
- blastic plasmacytoid dendritic cell neoplasm (1)
- blood flow recovery (1)
- bone-marrow (1)
- calorimeter: electromagnetic (1)
- center-of-mass energy (1)
- cerebral sinus and vein thrombosis (CVT) (1)
- charmonium-like states (1)
- cisplatin (1)
- cloacal malformation (1)
- coastal geomorphology (1)
- cohlear implant (1)
- collateral growth (1)
- combinatorics (1)
- comorbidity (1)
- component study (1)
- cone-beam computed tomography (CBCT) (1)
- cone-beam computer tomography (1)
- coronary artery disease (1)
- cytarabine dose (1)
- dE/dx (1)
- data quality (1)
- data structures (1)
- decompressive craniectomy (1)
- denervation (1)
- dimuon (1)
- dynamic vegetation model (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- early tumor stages (1)
- effectiveness (1)
- elderly (1)
- electric and acustic stymulation (1)
- electrical resistivity tomography (1)
- electroencephalography (EEG) (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- electron-positron collision (1)
- electronics: readout (1)
- endothelial function (1)
- erectile dysfunction (1)
- femoral artery ligation (1)
- fibre: optical (1)
- fibrosis imaging (1)
- fluid shear stress (1)
- foraminifera (1)
- functional genetics (1)
- geophysical prospections (1)
- global warming (1)
- hadron spectroscopy (1)
- hadronic events (1)
- haemophilia A (1)
- hearing loss (1)
- helicity amplitude analysis (1)
- hierarchies and reducibilities (1)
- immunohistochemistry (1)
- inclusive J/ψ decays (1)
- inner ear (1)
- intracerebral hemorrhage (ICH) (1)
- intratumoral (1)
- kidney formation (1)
- lipiodol (1)
- local radiotherapy (1)
- logic (1)
- lung cancer (1)
- mRNA active cancer immunotherapy (1)
- mRNA vaccine (1)
- magnetic gradiometry (1)
- micropalaeontology (1)
- microwave ablation (1)
- mindfulness (1)
- monocytes (1)
- multicenter study (1)
- mutually exclusive mutations (1)
- mycorrhiza (1)
- nanoparticle (1)
- natural reforestation (1)
- neurofibrillary pathology (1)
- neuropathological diagnosis (1)
- neutralizing antibodies (1)
- next generation sequencing (1)
- nitrogen deposition (1)
- non-small cell lung cancer (1)
- non‐selective beta‐blocker (1)
- nuclear cardiology (1)
- number of J/ψ events (1)
- nutrient cycling (1)
- permanent plots (1)
- plant community assembly (1)
- plant functional traits (1)
- plant succession (1)
- plasma-derived factor VIII concentrate, prophylaxis (1)
- portal hypertension (1)
- prognosis (1)
- prognostic biomarker (1)
- psychotherapy process (1)
- pulmonary hypertension (1)
- radiation (1)
- randomized controlled trial (RCT) (1)
- reactive systems (1)
- recurrent mutations (1)
- retrospective trial (1)
- rolipram (1)
- solitary pulmonary nodule (1)
- species composition (1)
- species richness (1)
- specification and verification (1)
- spike protein (1)
- spiral ganglion cell (1)
- stability (1)
- stent (1)
- succession (1)
- tetraquark (1)
- therapeutic alliance (1)
- tracheobronchomalacia (1)
- transbronchial biopsy (TBB) (1)
- trigger efficiency (1)
- tropical montane forests (TMF) (1)
- urinary tract development (1)
- vaccination (1)
- vaccine-induced immune thrombotic thrombocytopenia (VITT) (1)
- variants of concern (1)
- vegetation classification (1)
- verification (1)
- von Willebrand disease (1)
- windthrow (1)
- zebrafish development (1)
- Λ+c baryon (1)
- Σ hyperon (1)
Institute
We present the first observation of the singly Cabibbo-suppressed decay Λ+c→ΛK+π0 with a significance of 5.7σ and the first evidence of Λ+c→ΛK+π+π− decay with a significance of 3.1σ, based on e+e− annihilation data recorded by the BESIII detector at the BEPCII collider. The data correspond to an integrated luminosity of 6.4 fb−1, in the center-of-mass energy range from 4.600 GeV to 4.950 GeV. We determine the branching fractions of Λ+c→ΛK+π0 and Λ+c→ΛK+π+π− relative to their Cabibbo-favored counterparts to be B(Λ+c→ΛK+π0)B(Λ+c→Λπ+π0)=(2.09±0.39stat.±0.07syst.)×10−2 and B(Λ+c→ΛK+π+π−)B(Λ+c→Λπ+π+π−)=(1.13±0.41stat.±0.06syst.)×10−2, respectively. Moreover, by combining our measured result with the world average of B(Λ+c→Λπ+π0), we obtain the branching fraction B(Λ+c→ΛK+π0)=(1.49±0.27stat.±0.05syst.±0.08ref.)×10−3. This result significantly departs from theoretical predictions based on quark SU(3) flavor symmetry, which is underpinned by the presumption of meson pair S-wave amplitude dominance.
Using data samples with an integrated luminosity of 4.67 fb−1 collected by the BESIII detector operating at the BEPCII collider, we search for the process e+e−→η′ψ(2S) at center-of-mass energies from 4.66 to 4.95 GeV. No significant signal is observed, and upper limits for the Born cross sections σB(e+e−→η′ψ(2S)) at the 90\% confidence level are determined.
During the 2016-17 and 2018-19 running periods, the BESIII experiment collected 7.5~fb−1 of e+e− collision data at center-of-mass energies ranging from 4.13 to 4.44~GeV. These data samples are primarily used for the study of excited charmonium and charmoniumlike states. By analyzing the di-muon process e+e−→(γISR/FSR)μ+μ−, we measure the center-of-mass energies of the data samples with a precision of 0.6 MeV. Through a run-by-run study, we find that the center-of-mass energies were stable throughout most of the data-taking period.
Based on (2.712±0.014)×109 ψ(3686) events collected by the BESIII collaboration, evidence of the hadronic decay hc→K0SK+π−+c.c. is found with a significance of 4.3σ in the ψ(3686)→π0hc process. The branching fraction of hc→K0SK+π−+c.c. is measured to be (7.3±0.8±1.8)×10−4, where the first and second uncertainties are statistical and systematic, respectively. Combining with the exclusive decay width of ηc→KK¯π, our result indicates inconsistencies with both pQCD and NRQCD predictions.
Using data samples collected with the BESIII detector operating at the BEPCII storage ring, the cross section of the inclusive process e+e−→η+X, normalized by the total cross section of e+e−→hadrons, is measured at eight center-of-mass energy points from 2.0000 GeV to 3.6710 GeV. These are the first measurements with momentum dependence in this energy region. Our measurement shows a significant discrepancy from calculations with the existing fragmentation functions. To address this discrepancy, a new QCD analysis is performed at the next-to-next-to-leading order with hadron mass corrections and higher twist effects, which can explain both the established high-energy data and our measurements reasonably well.
Using 2.93 fb−1 of e+e− collision data collected with the BESIII detector at the center-of-mass energy 3.773 GeV, we perform the first amplitude analysis of the decay D+ → π+π0π0 and determine the relative magnitudes and phases of different intermediate processes. The absolute branching fraction of D+ → π+π0π0 is measured to be (2.888 ± 0.058stat. ± 0.069syst.)%. The dominant intermediate processes are D+ → a1(1260)+(→ ρ+π0) and D+ → *0ρ+, with branching fractions of (8.66 ± 1.04stat. ± 1.39syst.) × 10−3 and (9.70 ± 0.81stat. ± 0.53syst.) × 10−3, respectively.
The singly Cabibbo-suppressed decay D+s → K+π+π−π0 is observed by using a data set corresponding to an integrated luminosity of 6.32 fb−1 recorded by the BESIII detector at the centre-of-mass energies between 4.178 and 4.226 GeV. The first amplitude analysis of D+s → K+π+π−π0 reveals the sub-structures in this decay and determines the fractions and relative phases of different intermediate processes. The dominant intermediate process is D+s → K∗0ρ+, with a fit fraction of (40.5 ± 2.8stat. ± 1.5syst.)%. With the detection efficiency based on our amplitude analysis, the absolute branching fraction forD+s → K+π+π−π0 is measured to be (9.75 ± 0.54stat. ± 0.17syst.) × 10−3.
We present the first observation of the singly Cabibbo-suppressed decay Λ+𝑐→Λ𝐾+𝜋0 with a significance of 5.7𝜎 and the first evidence of Λ+𝑐→Λ𝐾+𝜋+𝜋− decay with a significance of 3.1𝜎, based on 𝑒+𝑒−annihilation data recorded by the BESIII detector at the BEPCII collider. The data correspond to an integrated luminosity of 6.4 fb−1, in the center-of-mass energy range from 4.600 to 4.950 GeV. We determine the branching fractions of Λ+𝑐→Λ𝐾+𝜋0 and Λ+𝑐→Λ𝐾+𝜋+𝜋− relative to their Cabibbo-favored counterparts to be ℬ(Λ+𝑐→Λ𝐾+𝜋0)ℬ(Λ+𝑐→Λ𝜋+𝜋0) = (2.09±0.39stat±0.07syst)×10−2 and ℬ(Λ+𝑐→Λ𝐾+𝜋+𝜋−)ℬ(Λ+𝑐→Λ𝜋+𝜋+𝜋−) = (1.13±0.41stat±0.06syst)×10−2, respectively. Moreover, by combining our measured result with the world average of ℬ(Λ+𝑐→Λ𝜋+𝜋0), we obtain the branching fraction ℬ(Λ+𝑐→Λ𝐾+𝜋0) = (1.49±0.27stat±0.05syst±0.08ref)×10−3. This result significantly departs from theoretical predictions based on quark 𝑆𝑈(3) flavor symmetry, which is underpinned by the presumption of meson pair 𝑆-wave amplitude dominance.
Based on 4.5 fb−1 of e+e− collision data accumulated at center-of-mass energies between 4599.53 MeV and 4698.82 MeV with the BESIII detector, the decay Λ+c→nK0Sπ+π0 is observed for the first time with a significance of 9.2σ. The branching fraction is measured to be (0.85±0.13±0.03)%, where the first uncertainty is statistical and the second systematic, which differs from the theoretical prediction based on isospin by 4.4σ. This indicates that there may be resonant contributions or some unknown dynamics in this decay.
We report a search for a dark photon using 14.9~fb−1 of e+e− annihilation data taken at center-of-mass energies from 4.13 to 4.60~GeV with the BESIII detector operated at the BEPCII storage ring. The dark photon is assumed to be produced in the radiative annihilation process of e+e− and to predominantly decay into light dark matter particles, which escape from the detector undetected. The mass range from 1.5 to 2.9~GeV is scanned for the dark photon candidate, and no significant signal is observed. The mass dependent upper limits at the 90% confidence level on the coupling strength parameter ϵ for a dark photon coupling with an ordinary photon vary between 1.6×10−3 and 5.7×10−3.